Earnings Call Insights: Abbott Laboratories (ABT) Q1 2025
Management View
- CEO Robert Ford highlighted the robust performance for Q1 2025, with high single-digit sales growth and double-digit earnings per share (EPS) growth. Adjusted EPS for the quarter was $1.09, representing an 11% increase compared to the prior